View Author
patient treatment myeloma lenalidomide study thalidomide therapy dexamethasone response blood bortezomib trial survival disease relapse len /dex month combination cycle expression result maintenance transplantation regimen melphalan women mirna cd 34ϩcd cells induction effect novel agents group table prednisone number agent ef ficacy phase 34ϩcd signi cell transplantation erasmus mc analysis figure randomized novel netherland outcome cancer department leukemia signi ficantly allogeneic university progression donor-derived bm mscs marrow diagnosis score hematology celgene protocol grade event autologou factor menorrhagia toxicity erasmu hsa-mir baseline difference ficacy center function allo-sct qlq-c allogeneic nma sct value response rate
10 Most Recent Publications
|
A phase 2 multicentre study of siltuximab, an anti-interleukin-6 monoclonal antibody, in patients with relapsed or refractory multiple myeloma
(Article)
Voorhees, P.M. Manges, R.F. Orlowski, R.Z. Kranenburg, B. Hall, D.B. Casneuf, T. Qin, X. Velde, H. van de Xie, H. Thomas, S.K. Sonneveld, P. Jagannath, S. Somlo, G. Krishnan, A. Lentzsch, S. Frank, R.C. Zweegman, S. Wijermans, P.W. |
2013-05-01
|
|
Gynaecological and obstetric bleeding in moderate and severe von willebrand disease
(Article)
Wee, E.M. de Knol, H.M. Meijer, K. Leebeek, F.W.G. Mauser-Bunschoten E. Bom, J.G. van der Eikenboom, J. Fijnvandraat, K. Goede-Bolder, A. de Gorkom, B.L.-V. Ypma, P.F. Zweegman, S. |
2011-11-01
|
|
MicroRNA signatures characterize multiple myeloma patients
(Article)
Corthals, S.L. Sun, S.M. Zweegman, S. Jongen-Lavrencic, M. Sonneveld, P. Kuiper, R. Knegt, Y. de Broyl, A. Holt, B. van der Beverloo, H.B. Peeters, J.K. Jarari, L. Lokhorst, H.M. |
2011-11-01
|
|
Personalized therapy in multiple myeloma according to patient age and vulnerability: A report of the European Myeloma Network (EMN)
(Article)
Palumbo, A. Bringhen, S. Zweegman, S. Terpos, E. Davies, F. Driessen, C. Gimsing, P. Gramatzki, M. Hajek, R. Johnsen, H.E. Da Costa, F.L. Sezer, O. Ludwig, H. Spencer, A. Beksaç, M. Morgan, G. Einsele, H. San Miguel, J. Sonneveld, P. Dimopoulos, M.A. Bladé, J. Mateos, M.V. Rosiñol, L. Boccadoro, M. Cavo, M. Lokhorst, H.M. |
2011-10-27
|
|
Lenalidomide maintenance after nonmyeloablative allogeneic stem cell transplantation in multiple myeloma is not feasible: Results of the HOVON 76 Trial
(Article)
Kneppers, E. Holt, B. van der Bruijnen, C.P. Emmelot, M. Sonneveld, P. Lokhorst, H.M. Mutis, T. Minnema, M.C. Kersten, M.J. Zweegman, S. Meijer, E. Huls, G. Cornelissen, J.J. Janssen, J.J. Huisman, C. Cornelisse, P.B. |
2011-09-01
|
|
Optimizing the use of lenalidomide in relapsed or refractory multiple myeloma: Consensus statement
(Article)
Dimopoulos, M.A. Palumbo, A. Ludwig, H. Mellqvist, U.H. Morgan, G. San Miguel, J-F. Zweegman, S. Sonneveld, P. Attal, M. Beksaç, M. Davies, F. Delforge, M. Einsele, H. Hajek, R. Harousseau, J-L. Da Costa, F.L. |
2011-05-01
|
|
Effect of thalidomide with melphalan and prednisone on health-related quality of life (HRQoL) in elderly patients with newly diagnosed multiple myeloma: a prospective analysis in a randomized trial
(Article)
Verelst, S.G.R. Termorshuizen, F. Lokhorst, H.M. Sonneveld, P. Wijermans, P. Uyl-de Groot, C.A. Schaafsma, M.R. Ammerlaan, A.H.M. Wittebol, S. Sinnige, H.A.M. Zweegman, S. Marwijk Kooy, M. van Griend, R. van der |
2011-04-07
|
|
European Myeloma Network: The 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma
(Article)
Engelhardt, M. Udi, J. Driessen, C. Patriarca, F. Gramatzki, M. Terpos, E. Sezer, O. Kropff, M. Straka, C. Johnsen, H.E. Waage, A. Boegsted, M. Kleber, M. Lokhorst, H.M. Hjek, R. Morgan, G. Boccadoro, M. Ludwig, H. Cavo, M. Polliack, A. Sonneveld, P. Einsele, H. Palumbo, A. Spencer, A. Rocci, A. Knop, S. Bruno, B. Bringhen, S. Pérez-Simn, J.A. Zweegman, S. |
2010-11-01
|
|
A randomized phase 3 study on the effect of thalidomide combined with adriamycin, dexamethasone, and high-dose melphalan, followed by thalidomide maintenance in patients with multiple myeloma
(Article)
Lokhorst, H.M. Holt, B. van der Wittebol, S. Delforge, M. Berenschot, H. Bos, G.M. Jie, K.S-G. Sinnige, H. Marwijk Kooy, M. van Joosten, P. Minnema, M.C. Ammerlaan, R. van Zweegman, S. Sonneveld, P. Vellenga, E. Croockewit, S. Oers, M.H.J. van von dem Borne, P.A. Wijermans, P.W. Schaafsma, R. de Weerdt, O. |
2010-02-11
|
|
Current multiple myeloma treatment strategies with novel agents: A European perspective
(Article)
Ludwig, H. Beksac, M. Goldschmidt, H. Harousseau, J-L. Hess, U. Ketterer, N. Kropff, M. Mendeleeva, L. Morgan, G. Palumbo, A. Plesner, T. San Miguel, J-F. Bladé, J. Shpilberg, O. Sondergeld, P. Sonneveld, P. Zweegman, S. Boccadoro, M. Cavenagh, J. Cavo, M. Dimopoulos, M.A. Drach, J. Einsele, H. Facon, T. |
2010-02-05
|
